Breast Cancer
Conference Coverage
Tamoxifen at 5 mg halves recurrence of breast intraepithelial neoplasia
SAN ANTONIO – For patients with ADH, DCIS, or LCIS, one-fourth of the standard dose reduced risk for both invasive disease/DCIS and contralateral...
Conference Coverage
RT of lymph nodes as good as dissection for the long-term
SAN ANTONIO – Both axillary RT and axillary lymph node dissection provide excellent, comparable locoregional control in patients with early-stage...
Conference Coverage
Nothing to gain from chemo after pCR achieved
SAN ANTONIO - The only thing women with localized breast cancer who achieve a pCR after neoadjuvant chemo may gain from further chemo from...
Latest News
Low-dose tamoxifen halves recurrence of breast intraepithelial neoplasia
SAN ANTONIO – Women with breast intraepithelial neoplasms who took tamoxifen for 3 years at a dose of 5 mg per day had a 50% reduction in risk of...
Conference Coverage
Adjuvant capecitabine found disappointing in TNBC
SAN ANTONIO – A phase 3 trial was negative, showing that adding adjuvant capecitabine to surgery and chemotherapy does not improve survival in...
Conference Coverage
Adjuvant T-DM1 halves HER2-positive invasive breast cancer recurrence
SAN ANTONIO – The 3-year invasive disease-free recurrence was 88.3% for patients with residual disease treated with T-DM1 versus 77.0% with...
From the Editor
Maternal health benefits of breastfeeding
Diseases highly prevalent among women include type 2 diabetes, hypertension, and coronary artery disease, as well as breast, ovarian, and...
Conference Coverage
PD-L1 expression best predicts response to atezolizumab + nab-paclitaxel for mTNBC
SAN ANTONIO – IMpassion130 analyses show that PD-L1 expression on tumor-infiltrating immune cells is the best...
Conference Coverage
No boost in OS with addition of capecitabine for early TNBC
SAN ANTONIO – Adding adjuvant capecitabine to surgery and standard chemotherapy did not improve disease-free or overall survival in women with...
Commentary
Intervention may improve genetic testing for HBOC
Improving genetic screening and testing completion rates requires a coordinated effort.
From the Journals
ICYMI: Hereditary cancer screening feasible in community gynecologic practices